GSKCONS

GSKCONS: Members of the Exchange are hereby informed that the trading in Equity Shares of GlaxoSmithKline Consumer Healthcare Limited shall be suspended w.e.f. April 16, 2020 (i.e. closing hours of trading on April 15, 2020) on account of Scheme of Amalgamation with Hindustan Unilever Limited.

The Exchange had sought clarification from the Company with respect to news item captioned- "Maharashtra FDA notice for Colgate brand Sensodyne for misleading consumers". In this regard, you are advised to provide clarification/confirmation on the news item in detail including the following: a) Whether such event stated in published news were taking place? If so, you are advised to provide the said information along with the sequence of events in chronological order. b) The material impact of this article on the Company. c) Whether company are aware of any information that has not been announc

��The Exchange has sought clarification from the Company with respect to news item captioned- "Maharashtra FDA notice for Colgate brand Sensodyne for misleading consumers". In this regard, you are advised to provide clarification/confirmation on the news item in detail including the following: a) Whether such event stated in published news were taking place? If so, you are advised to provide the said information along with the sequence of events in chronological order. b) The material impact of this article on the Company. c) Whether company are aware of any information that has not been annou

The Exchange has sought clarification from GlaxoSmithKline Consumer Healthcare Limited with respect to recent news item captioned "Unilever may pip Nestle to buy GSK's India unit.". The Exchange, in order to verify the accuracy or otherwise of the information reported in the media and to inform the market place so that the interest of the investors is safeguarded, had written to the company. GlaxoSmithKline Consumer Healthcare Limited has submitted their response.

The Exchange has sought clarification from GlaxoSmithKline Consumer Healthcare Limited with respect to recent news item captioned "Unilever may pip Nestle to buy GSK's India unit.". In this regard, Exchange have advised the Company to provide clarification/confirmation on the news item in detail including the following: a) Whether such negotiations were taking place and b) Whether you/company are aware of any information that has not been announced to the Exchanges which could explain the aforesaid movement in the trading. The response from the company is awaited.

The Exchange has sought clarification from GlaxoSmithKline Consumer Healthcare Limited with respect to recent news item captioned "Coca Cola plans to boost muscle with Horlicks buy". The Exchange, in order to verify the accuracy or otherwise of the information reported in the media and to inform the market place so that the interest of the investors is safeguarded, had written to the company. GlaxoSmithKline Consumer Healthcare Limited has submitted their response.

The Exchange has sought clarification from GlaxoSmithKline Consumer Healthcare Limited with respect to recent news item captioned Coca Cola plans to boost muscle with Horlicks buy. In this regard, Exchange have advised the Company to provide clarification/confirmation on the news item in detail including the following: a) Whether such negotiations were taking place and b) Whether you/company are aware of any information that has not been announced to the Exchanges which could explain the aforesaid movement in the trading. The response from the company is awaited.

GSKCONS:The Exchange had sought clarification from GlaxoSmithKline Consumer Healthcare Limited with respect to announcement dated 06-Dec-2017, regarding Change in Director(s) of the company.". On basis of above the Company is required to clarify following: 1. Brief profile (in case of appointment); The response of the Company is as follow- Mr Navneet Saluja has completed his MBA from Jamnalal Bajaj Institute of Management in 1987. Mr Navneet Saluja started his career with Cadbury India as a Management Trainee. He then had a long and successful stint with Gillette India. In his last role with

GSKCONS:The Exchange has sought clarification from GlaxoSmithKline Consumer Healthcare Limited with respect to announcement dated 06-Dec-2017, regarding Change in Director(s) of the company.". On basis of above the Company is required to clarify following: 1. Brief profile (in case of appointment); The response of the Company is awaited.

The Exchange had sought clarification from the Company with respect to announcement submitted to the Exchange dated June 15, 2016 regarding resumption of operations which were temporary suspended at Company's factory located at Nabha, Patiala - 147201.On basis of above, the Reply of the Company is attached.

The Exchange has sought clarification from GlaxoSmithKline Consumer Healthcare Limited with respect to announcement submitted to the Exchange dated June 15, 2016 regarding resumption of operations which were temporary suspended at Company's factory located at Nabha, Patiala - 147201On basis of above Company is required to clarify that :1. Financial impact on the Company during such suspension period. The reply from the Company is awaited.

The Exchange had sought clarification from GlaxoSmithKline Consumer Healthcare Limited with respect to recent news item captioned "FSSAI orders testing of GSK, ITC fast food brands". The Company has clarified on August 07, 2015 that "We had as on that date not received any communication from FSSAI Authorities regarding our brand Foodles. We will provide all support to the authorities and ensure that we remain in complete compliance with the law. GlaxoSmithKline Consumer Healthcare Ltd is a responsible company driven by values and committed to bring the best for our consumers".

The Exchange has sought clarification GlaxoSmithKline Consumer Healthcare Limited with respect to recent news item captioned "FSSAI orders testing of GSK, ITC fast food brands". In this regard, the Exchange has advised the Company to provide clarification/confirmation on the news item in detail including the following : Whether company are aware of any information that has not been announced to the Exchanges under clause 36 of the Listing Agreement. The reply from the Company is awaited.

The Exchange had sought clarification from GlaxoSmithKline Consumer Healthcare Limited with respect to news item captioned "GSK Consumer fined for overcharging". The Company has clarified that "No comments as Crocin is not a brand of the listed entity GlaxoSmithKline Consumer Healthcare Limited. We would like to state that Crocin is GlaxoSmithKline Asia Private Limited s brand and is not related to the listed entity GlaxoSmithKline Consumer Healthcare Limited. Therefore, there is no material impact of this article on the Company".

Glaxosmithkline Consumer Healthcare Limited has informed the Exchange regarding the article titled "Britannia set for global buys in health foods" in Economic Times on September 01,2006. In this connection the company has clarified as under: "Glaxosmithkline Consumer Healthcare Limited denies any move to divest its Nutritional portfolio and assures all its stakeholders that the reportage is based on conjecture and has no basis in truth whatsoever".